SCHULMAN AMY W
Insider CIK 1438226 · ELV Director · ALNY Director · BIND Director · IRWD Director · ASNS Director · ZTS Director · GUTS Director · SQZ Director, 10% owner · BUFF Director · CAMP 10% owner · CYCN Director · HCII Director · PFE Former Exec. Vice President
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2026-05-20 | 2026-05-22 | 1,802 | — | $0 | 1,802 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2026-05-20 | 2026-05-22 | 838 | — | $0 | 24,049 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2026-05-13 | 2026-05-14 | 11,250 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2026-05-13 | 2026-05-14 | 11,250 | $70.20 | $789.8K | 23,211 | SEC↗ |
| ELV Elevance Health, Inc. | A Award | 2026-05-13 | 2026-05-15 | 563 | — | $0 | 781 | SEC↗ |
| ELV Elevance Health, Inc. | S Sale | 2026-03-12 | 2026-03-23 | 26 | $287.50 | $7.5K | 218 | SEC↗ |
| ELV Elevance Health, Inc. | A Award | 2026-02-02 | 2026-02-03 | 218 | — | $0 | 218 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | P Buy | 2025-09-11 | 2025-09-11 | 1,221,721 | $1.53 | $1.87M | 2,825,500 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | P Buy | 2025-09-11 | 2025-09-11 | 85,468 | $1.53 | $130.8K | 197,661 | SEC↗ |
| GUTS FRACTYL HEALTH, INC. | A Award deriv | 2025-06-11 | 2025-06-13 | 22,500 | — | $0 | 22,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2025-05-08 | 2025-05-12 | 1,558 | — | $0 | 1,558 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2025-05-08 | 2025-05-12 | 775 | — | $0 | 11,961 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2025-03-13 | 2025-03-14 | 2,750 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2025-03-13 | 2025-03-14 | 2,750 | $131.21 | $360.8K | 11,186 | SEC↗ |
| GUTS FRACTYL HEALTH, INC. | P Buy | 2025-03-13 | 2025-03-17 | 8,550 | $1.17 | $10.0K | 8,550 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion deriv | 2024-10-15 | 2024-10-15 | 980,829 | — | $0 | 0 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion deriv | 2024-10-15 | 2024-10-15 | 14,020,475 | — | $0 | 0 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion deriv | 2024-10-15 | 2024-10-15 | 3,967,234 | — | $0 | 0 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion deriv | 2024-10-15 | 2024-10-15 | 277,536 | — | $0 | 0 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion deriv | 2024-10-15 | 2024-10-22 | 3,967,234 | — | $0 | 0 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion deriv | 2024-10-15 | 2024-10-22 | 14,020,475 | — | $0 | 0 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion deriv | 2024-10-15 | 2024-10-22 | 277,536 | — | $0 | 0 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion deriv | 2024-10-15 | 2024-10-22 | 980,829 | — | $0 | 0 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion | 2024-10-15 | 2024-10-15 | 353,718 | — | $0 | 1,603,779 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | P Buy | 2024-10-15 | 2024-10-15 | 909,090 | $11.00 | $10.00M | 909,090 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion | 2024-10-15 | 2024-10-15 | 24,745 | — | $0 | 112,193 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion | 2024-10-15 | 2024-10-15 | 1,250,061 | — | $0 | 1,250,061 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion | 2024-10-15 | 2024-10-15 | 87,448 | — | $0 | 87,448 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion | 2024-10-15 | 2024-10-22 | 24,745 | — | $0 | 112,193 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion | 2024-10-15 | 2024-10-22 | 353,718 | — | $0 | 1,603,779 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion | 2024-10-15 | 2024-10-22 | 87,448 | — | $0 | 87,448 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion | 2024-10-15 | 2024-10-22 | 1,250,061 | — | $0 | 1,250,061 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | P Buy | 2024-10-15 | 2024-10-22 | 909,090 | $11.00 | $10.00M | 909,090 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2024-06-25 | 2024-06-27 | 8,500 | — | $0 | 2,750 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2024-06-25 | 2024-06-27 | 8,500 | $131.21 | $1.12M | 16,936 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-06-25 | 2024-06-27 | 8,500 | $240.00 | $2.04M | 8,436 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2024-05-29 | 2024-05-31 | 30,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-05-29 | 2024-05-31 | 10,121 | $148.21 | $1.50M | 20,015 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-05-29 | 2024-05-31 | 11,516 | $148.93 | $1.72M | 8,499 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-05-29 | 2024-05-31 | 63 | $149.76 | $9.4K | 8,436 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2024-05-29 | 2024-05-31 | 30,000 | $66.83 | $2.00M | 30,136 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2024-05-16 | 2024-05-20 | 5,228 | — | $0 | 5,228 | SEC↗ |
| GUTS Fractyl Health, Inc. | A Award deriv | 2024-02-01 | 2024-02-05 | 45,000 | — | $0 | 45,000 | SEC↗ |
| SQZ SQZ Biotechnologies Co | A Award deriv | 2023-06-14 | 2023-06-15 | 39,875 | — | $0 | 39,875 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2023-05-18 | 2023-05-19 | 3,454 | — | $0 | 3,454 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2023-02-23 | 2023-02-27 | 136 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2023-02-23 | 2023-02-27 | 136 | — | $0 | 136 | SEC↗ |
| SQZ SQZ Biotechnologies Co | A Award deriv | 2022-06-15 | 2022-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2022-05-18 | 2022-05-20 | 5,153 | — | $0 | 5,153 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2022-02-23 | 2022-02-25 | 136 | — | $0 | 136 | SEC↗ |
| SQZ SQZ Biotechnologies Co | M Exercise deriv | 2021-12-22 | 2021-12-23 | 6,581 | — | $0 | 3,949 | SEC↗ |
| SQZ SQZ Biotechnologies Co | M Exercise deriv | 2021-12-22 | 2021-12-23 | 7,458 | — | $0 | 3,072 | SEC↗ |
| SQZ SQZ Biotechnologies Co | M Exercise deriv | 2021-12-22 | 2021-12-23 | 10,091 | — | $0 | 439 | SEC↗ |
| SQZ SQZ Biotechnologies Co | M Exercise | 2021-12-22 | 2021-12-23 | 7,458 | $4.59 | $34.2K | 208,233 | SEC↗ |
| SQZ SQZ Biotechnologies Co | M Exercise | 2021-12-22 | 2021-12-23 | 6,581 | $4.59 | $30.2K | 214,814 | SEC↗ |
| SQZ SQZ Biotechnologies Co | M Exercise | 2021-12-22 | 2021-12-23 | 10,091 | $2.02 | $20.4K | 200,775 | SEC↗ |
| SQZ SQZ Biotechnologies Co | P Buy | 2021-12-13 | 2021-12-15 | 1,850 | $10.94 | $20.2K | 1,850 | SEC↗ |
| SQZ SQZ Biotechnologies Co | P Buy | 2021-12-13 | 2021-12-15 | 1,850 | $10.88 | $20.1K | 1,850 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2021-10-27 | 2021-10-29 | 1,814 | — | $0 | 1,814 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2021-07-15 | 2021-07-19 | 4,032 | — | $0 | 4,032 | SEC↗ |
| SQZ SQZ Biotechnologies Co | A Award deriv | 2021-06-15 | 2021-06-17 | 10,500 | — | $0 | 10,500 | SEC↗ |
| HCII Hudson Executive Investmen | P Buy deriv | 2021-04-13 | 2021-04-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SQZ SQZ Biotechnologies Co | C Conversion deriv | 2020-11-03 | 2020-11-03 | 168,698 | — | $0 | 0 | SEC↗ |
| SQZ SQZ Biotechnologies Co | C Conversion deriv | 2020-11-03 | 2020-11-03 | 56,462 | — | $0 | 0 | SEC↗ |
| SQZ SQZ Biotechnologies Co | C Conversion deriv | 2020-11-03 | 2020-11-03 | 412,608 | — | $0 | 0 | SEC↗ |
| SQZ SQZ Biotechnologies Co | C Conversion deriv | 2020-11-03 | 2020-11-03 | 28,863 | — | $0 | 0 | SEC↗ |
| SQZ SQZ Biotechnologies Co | C Conversion deriv | 2020-11-03 | 2020-11-03 | 348,725 | — | $0 | 0 | SEC↗ |
| SQZ SQZ Biotechnologies Co | C Conversion deriv | 2020-11-03 | 2020-11-03 | 93,279 | — | $0 | 0 | SEC↗ |
| SQZ SQZ Biotechnologies Co | C Conversion deriv | 2020-11-03 | 2020-11-03 | 630,672 | — | $0 | 0 | SEC↗ |
| SQZ SQZ Biotechnologies Co | C Conversion deriv | 2020-11-03 | 2020-11-03 | 44,120 | — | $0 | 0 | SEC↗ |
| SQZ SQZ Biotechnologies Co | C Conversion deriv | 2020-11-03 | 2020-11-03 | 807,096 | — | $0 | 0 | SEC↗ |
| SQZ SQZ Biotechnologies Co | C Conversion deriv | 2020-11-03 | 2020-11-03 | 24,396 | — | $0 | 0 | SEC↗ |
| SQZ SQZ Biotechnologies Co | C Conversion deriv | 2020-11-03 | 2020-11-03 | 21,087 | — | $0 | 0 | SEC↗ |
| SQZ SQZ Biotechnologies Co | C Conversion | 2020-11-03 | 2020-11-03 | 2,315,652 | — | $0 | 2,315,652 | SEC↗ |
| SQZ SQZ Biotechnologies Co | C Conversion | 2020-11-03 | 2020-11-03 | 161,994 | — | $0 | 161,994 | SEC↗ |
| SQZ SQZ Biotechnologies Co | C Conversion | 2020-11-03 | 2020-11-03 | 22,204 | — | $0 | 190,684 | SEC↗ |
| SQZ SQZ Biotechnologies Co | P Buy | 2020-11-03 | 2020-11-03 | 16,346 | $16.00 | $261.5K | 178,340 | SEC↗ |
| SQZ SQZ Biotechnologies Co | P Buy | 2020-11-03 | 2020-11-03 | 233,654 | $16.00 | $3.74M | 2,549,306 | SEC↗ |
| SQZ SQZ Biotechnologies Co | C Conversion | 2020-11-03 | 2020-11-03 | 275,860 | — | $0 | 275,860 | SEC↗ |
| SQZ SQZ Biotechnologies Co | A Award deriv | 2020-10-29 | 2020-10-30 | 7,055 | — | $0 | 7,055 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2020-07-01 | 2020-07-06 | 4,581 | — | $0 | 4,581 | SEC↗ |
| CYCN Cyclerion Therapeutics, In | A Award deriv | 2020-06-16 | 2020-06-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-07-01 | 2019-07-02 | 9,000 | — | $0 | 9,000 | SEC↗ |
| CYCN Cyclerion Therapeutics, In | A Award deriv | 2019-06-01 | 2019-06-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CYCN Cyclerion Therapeutics, In | P Buy | 2019-04-08 | 2019-04-10 | 604,482 | $16.00 | $9.67M | 604,482 | SEC↗ |
| CYCN Cyclerion Therapeutics, In | P Buy | 2019-04-08 | 2019-04-10 | 21,635 | $16.00 | $346.2K | 21,635 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | D To issuer | 2019-04-01 | 2019-04-03 | 4,056 | — | $0 | 38,242 | SEC↗ |
| CYCN Cyclerion Therapeutics, In | A Award | 2019-04-01 | 2019-04-03 | 3,279 | — | $0 | 7,508 | SEC↗ |
| CYCN Cyclerion Therapeutics, In | A Award | 2019-04-01 | 2019-04-03 | 4,229 | — | $0 | 4,229 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2019-03-15 | 2019-03-19 | 183 | — | $0 | 42,298 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2018-12-14 | 2018-12-18 | 212 | — | $0 | 42,115 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2018-09-14 | 2018-09-18 | 136 | — | $0 | 41,903 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-06-20 | 2018-06-22 | 9,000 | — | $0 | 9,000 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2018-06-15 | 2018-06-19 | 126 | — | $0 | 41,767 | SEC↗ |
| ASNS Arsanis, Inc. | A Award deriv | 2018-06-05 | 2018-06-07 | 10,000 | — | $0 | 10,000 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2018-05-31 | 2018-06-04 | 16,223 | — | $0 | 41,641 | SEC↗ |
| BUFF Blue Buffalo Pet Products, | D To issuer | 2018-04-24 | 2018-04-24 | 14,819 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | A Award deriv | 2017-11-15 | 2018-03-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ASNS Arsanis, Inc. | A Award deriv | 2017-11-15 | 2017-12-01 | 7,324 | — | $0 | 7,324 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2017-06-02 | 2017-06-06 | 11,250 | — | $0 | 11,250 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2017-05-31 | 2017-06-02 | 15,625 | — | $0 | 25,418 | SEC↗ |
| BUFF Blue Buffalo Pet Products, | A Award | 2017-03-31 | 2017-04-04 | 3,695 | — | $0 | 14,819 | SEC↗ |
| IRWD IRONWOOD PHARMACEUTICALS I | A Award | 2017-01-01 | 2017-01-04 | 9,793 | — | $0 | 9,793 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2016-06-03 | 2016-06-07 | 11,250 | — | $0 | 11,250 | SEC↗ |
| BUFF Blue Buffalo Pet Products, | A Award | 2016-04-01 | 2016-04-05 | 3,324 | — | $0 | 11,124 | SEC↗ |
| BIND BIND Therapeutics, Inc | A Award deriv | 2015-06-09 | 2015-06-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2015-06-01 | 2015-06-03 | 11,250 | — | $0 | 11,250 | SEC↗ |
| BIND BIND Therapeutics, Inc | A Award deriv | 2014-09-03 | 2014-09-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2014-07-01 | 2014-07-02 | 30,000 | — | $0 | 30,000 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2013-12-31 | 2014-01-02 | 59 | $30.63 | $1.8K | 5,075 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2013-12-13 | 2013-12-16 | 60 | $30.25 | $1.8K | 5,016 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2013-11-27 | 2013-12-02 | 57 | $31.88 | $1.8K | 4,956 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2013-11-15 | 2013-11-18 | 123 | $32.00 | $3.9K | 4,929 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2013-10-31 | 2013-11-04 | 56 | $30.69 | $1.7K | 4,806 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2013-10-15 | 2013-10-16 | 65 | $29.16 | $1.9K | 4,750 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2013-09-30 | 2013-10-02 | 59 | $28.73 | $1.7K | 4,685 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2013-09-13 | 2013-09-17 | 64 | $28.51 | $1.8K | 4,626 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2013-08-30 | 2013-09-04 | 65 | $28.21 | $1.8K | 4,562 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2013-08-15 | 2013-08-16 | 63 | $28.80 | $1.8K | 4,497 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2013-07-31 | 2013-08-01 | 97 | $29.23 | $2.8K | 4,434 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2013-07-15 | 2013-07-16 | 63 | $28.79 | $1.8K | 4,337 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2013-06-28 | 2013-07-02 | 64 | $28.01 | $1.8K | 4,274 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2013-06-14 | 2013-06-18 | 61 | $29.09 | $1.8K | 4,210 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2013-05-31 | 2013-06-03 | 69 | $27.23 | $1.9K | 4,149 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2013-05-15 | 2013-05-16 | 94 | $29.56 | $2.8K | 4,080 | SEC↗ |
| PFE PFIZER INC | S Sale | 2013-05-15 | 2013-05-16 | 5,268 | $29.34 | $154.6K | 250,203 | SEC↗ |
| PFE PFIZER INC | S Sale | 2013-05-15 | 2013-05-16 | 4,701 | $29.40 | $138.2K | 255,471 | SEC↗ |
| PFE PFIZER INC | S Sale | 2013-05-15 | 2013-05-16 | 4,500 | $29.29 | $131.8K | 260,172 | SEC↗ |
| PFE PFIZER INC | S Sale | 2013-05-15 | 2013-05-16 | 3,999 | $29.36 | $117.4K | 264,672 | SEC↗ |
| PFE PFIZER INC | S Sale | 2013-05-15 | 2013-05-16 | 3,807 | $29.37 | $111.8K | 268,671 | SEC↗ |
| PFE PFIZER INC | S Sale | 2013-05-15 | 2013-05-16 | 3,802 | $29.39 | $111.7K | 272,478 | SEC↗ |
| PFE PFIZER INC | S Sale | 2013-05-15 | 2013-05-16 | 3,800 | $29.30 | $111.3K | 276,280 | SEC↗ |
| PFE PFIZER INC | S Sale | 2013-05-15 | 2013-05-16 | 2,400 | $29.31 | $70.3K | 283,672 | SEC↗ |
| PFE PFIZER INC | S Sale | 2013-05-15 | 2013-05-16 | 2,259 | $29.33 | $66.3K | 286,072 | SEC↗ |
| PFE PFIZER INC | S Sale | 2013-05-15 | 2013-05-16 | 2,005 | $29.43 | $59.0K | 288,331 | SEC↗ |
| PFE PFIZER INC | S Sale | 2013-05-15 | 2013-05-16 | 1,956 | $29.38 | $57.5K | 290,336 | SEC↗ |
| PFE PFIZER INC | S Sale | 2013-05-15 | 2013-05-16 | 805 | $29.44 | $23.7K | 292,292 | SEC↗ |
| PFE PFIZER INC | S Sale | 2013-05-15 | 2013-05-16 | 300 | $29.46 | $8.8K | 293,097 | SEC↗ |
| PFE PFIZER INC | S Sale | 2013-05-15 | 2013-05-16 | 100 | $29.45 | $2.9K | 293,397 | SEC↗ |
| PFE PFIZER INC | S Sale | 2013-05-15 | 2013-05-16 | 5,700 | $29.32 | $167.1K | 244,503 | SEC↗ |
| PFE PFIZER INC | S Sale | 2013-05-15 | 2013-05-16 | 10,408 | $29.41 | $306.1K | 234,095 | SEC↗ |
| PFE PFIZER INC | S Sale | 2013-05-15 | 2013-05-16 | 10,598 | $29.35 | $311.1K | 223,497 | SEC↗ |
| PFE PFIZER INC | S Sale | 2013-05-15 | 2013-05-16 | 3,592 | $29.42 | $105.7K | 280,080 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2013-04-30 | 2013-05-01 | 62 | $29.07 | $1.8K | 3,986 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2013-04-15 | 2013-04-17 | 59 | $30.45 | $1.8K | 3,924 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2013-03-28 | 2013-04-01 | 60 | $28.86 | $1.7K | 3,865 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2013-03-15 | 2013-03-18 | 60 | $28.02 | $1.7K | 3,805 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2013-02-28 | 2013-03-04 | 137,112 | — | $0 | 137,112 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2013-02-28 | 2013-03-04 | 165,198 | — | $0 | 165,198 | SEC↗ |
| PFE PFIZER INC | F Tax w/h | 2013-02-28 | 2013-03-04 | 20,336 | $27.37 | $556.6K | 292,167 | SEC↗ |
| PFE PFIZER INC | A Award | 2013-02-28 | 2013-03-04 | 27,943 | — | $0 | 312,503 | SEC↗ |
| PFE PFIZER INC | A Award | 2013-02-28 | 2013-03-04 | 36,430 | — | $0 | 284,560 | SEC↗ |
| ZTS Zoetis Inc. | P Buy | 2013-02-06 | 2013-02-08 | 5,000 | $26.00 | $130.0K | 5,000 | SEC↗ |
| PFE PFIZER INC | M Exercise deriv | 2012-12-06 | 2012-12-07 | 100,000 | — | $0 | 0 | SEC↗ |
| PFE PFIZER INC | M Exercise | 2012-12-06 | 2012-12-07 | 100,000 | $17.47 | $1.75M | 346,656 | SEC↗ |
| PFE PFIZER INC | S Sale | 2012-12-06 | 2012-12-07 | 100,000 | $25.56 | $2.56M | 246,656 | SEC↗ |
| PFE PFIZER INC | A Award | 2012-02-24 | 2012-02-27 | 37,626 | — | $0 | 261,348 | SEC↗ |
| PFE PFIZER INC | F Tax w/h | 2012-02-24 | 2012-02-27 | 18,990 | $21.18 | $402.2K | 242,358 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2012-02-23 | 2012-02-27 | 169,903 | — | $0 | 169,903 | SEC↗ |
| PFE PFIZER INC | A Award deriv | 2012-02-23 | 2012-02-27 | 144,033 | — | $0 | 144,033 | SEC↗ |
| PFE PFIZER INC | A Award | 2012-02-23 | 2012-02-27 | 32,988 | — | $0 | 223,722 | SEC↗ |